DrugsControl Media Services

News Detail

Phase II Clinical Trial of Niclosamide Drug for Treatment of Covid-19 Patients Begins (25-07-2021)

Hyderabad, 22 July 2021: The CSIR and Laxai Life Sciences Private Limited have initiated phase II clinical trials of anti-helminitic drug Niclosamide’ for the treatment of COVID-19 patients, a statement said on Sunday. The trial is a multi-centric, randomised, open label cl......
View Details

Source : Yahoo News

Related News